Martin Shkreli, the former drug-company executive criticized for dramatically raising a pill’s price, has asked a congressional committee seeking his testimony to guarantee it can’t be used in a federal prosecution, according to materials reviewed by The Wall Street Journal.
from WSJ.com: US Business http://ift.tt/1S7YerW
via IFTTT
No comments:
Post a Comment